” Even though the Ricaurte Tale was unfolding, MAPS ultimately gained FDA signal-off with a protocol for human trials of MDMA as being a remedy for PTSD, but only after it bought a $one million insurance coverage plan to indemnify the overview board.In the 1990s, the FDA authorized the 1st human trial analyzing usage of MDMA to relieve pain in te… Read More